Items where Author is " Margeli Mireia"

Agrawal Yash N and Fernandez-Martinez Aranzazu and Gil-Gil Miguel and Zielinski Christoph and Ruiz-Borrego Manuel and Ciruelos Eva Maria and Munoz Montserrat and Margeli Mireia and Bermejo Begona and Anton Antonio and Kahán Zsuzsanna and Csöszi Tibor and Alonso-Romero Jose Luis and Garcia-Saenz Jose Angel and Sanchez-Rovira Pedro and Alvarez Elena and Chacon Jose Ignacio and Gonzalez-Santiago Santiago and Rodriguez Cesar A and Servitja Sonia and Pfefferle Adam D and Herranz Jesus and Liu Yuan and Carey Lisa A and Romero-Camarero Isabel and Caballero Rosalia and Guerrero-Zotano Angel and Perou Charles M and Martin Miguel: Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
JCO PRECISION ONCOLOGY, 9. ISSN 2473-4284 (2025)

Martin Miguel and Zielinski Christoph and Ruiz-Borrego Manuel and Carrasco Eva and Ciruelos Eva M. and Munoz Montserrat and Bermejo Begona and Margeli Mireia and Csoszi Tibor and Anton Antonio and Turner Nicholas and Casas Maria I and Morales Serafin and Alba Emilio and Calvo Lourdes and De La Haba-Rodriguez Juan and Ramos Manuel and Murillo Laura and Santaballa Ana and Alonso-Romero Jose L. and Sanchez-Rovira Pedro and Corsaro Massimo and Huang Xin and Thallinger Christiane and Kahán Zsuzsanna and Gil-Gil Miguel: Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
EUROPEAN JOURNAL OF CANCER, 168. pp. 12-24. ISSN 0959-8049 (2022)

Kahán Zsuzsanna and Gil-Gil Miguel and Ruiz-Borrego Manuel and Carrasco Eva and Ciruelos Eva and Muñoz Montserrat and Bermejo Begoña and Margeli Mireia and Antón Antonio and Casas Maribel and Csöszi Tibor and Murillo Laura and Morales Serafín and Calvo Lourdes and Láng István: Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
EUROPEAN JOURNAL OF CANCER, 156. pp. 70-82. ISSN 0959-8049 (2021)